Stem Cell Transplantation in Ocular Lesions of Behcet's Disease

Retinitis Clinical Trial

Official title:
Phase 1 Study of Bone Marrow - Derived Stem Cell in the Treatment of Ocular Lesions of Behcet's Disease

Status Terminated

Clinical Trial Summary

The purpose of this study is to find if autologous stem cell transplantation can stop the progression of intractable eye lesions of Behcet's Disease or even to improve it.

Clinical Trial Description

To test in a pilot study the effect of autologous stem cell transplantation in stopping the progression of retinal damage of eye lesions in Behcet's Disease by repairing the vascular damage, and possibly to improve the lesions. ;

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00550498
Study type	Interventional
Source	Tehran University of Medical Sciences
Contact
Status	Terminated
Phase	Phase 1
Start date	December 2007
Completion date	July 2013

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04123626` - A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO Gene	Phase 1/Phase 2
Completed	`NCT03753893` - Ocular Manifestations in Rheumatic Diseases
Completed	`NCT00001734` - Screening for NEI Clinical Studies	N/A
Completed	`NCT04945772` - Efficacy and Safety of MCO-010 Optogenetic Therapy in Adults With Retinitis Pigmentosa [RESTORE]	Phase 2
Enrolling by invitation	`NCT06162585` - Non-Interventional Long Term Follow-up Study of Participants Previously Enrolled in the RESTORE Study